BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6509200)

  • 1. [Antibody-dependent cell cytotoxicity and the effect of interferon on K-cell functional activity in vitro in chronic viral hepatitis B in children].
    Kaganov BS; Zimin IuI; Uchaĭkin VF; Saidov MZ; Sorokin AM
    Biull Eksp Biol Med; 1984 Dec; 98(12):700-2. PubMed ID: 6509200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
    Müller C; Zielinski CC
    Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
    Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
    Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody-dependent and natural cellular cytotoxicity in patients with dilated cardiomyopathy].
    Bakhov NI; Aleksandrova LZ; Osipov SG; Naumov VG; Rudnev VI
    Ter Arkh; 1986; 58(10):62-7. PubMed ID: 3798351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the NK reaction in the diagnostics of liver and pancreas tumours.
    Karácsonyi S; Mándi Y; Farkas G; Tóth M; Béládi I
    Acta Chir Hung; 1985; 26(1):51-8. PubMed ID: 4002971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
    Koren HS; Brandt CP; Tso CY; Laszlo J
    J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cianidanol on natural killer cell activity in patients with chronic B virus hepatitis.
    Pár A; Szekeres-Bartho J; Pácsa S; Jávor T
    Int J Clin Pharmacol Res; 1987; 7(4):301-6. PubMed ID: 3596873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon on antibody-dependent cellular cytotoxicity (ADCC) in chickens.
    Mándi Y; Bakay M; Béládi I
    Acta Microbiol Hung; 1984; 31(2):127-33. PubMed ID: 6464658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic staging of chronic active hepatitis B patients in Hawaii.
    Ching N; Lumeng J; Pon E; Ching CY
    Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer activity in patients with acute viral hepatitis.
    Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
    Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular nature of concanavalin A-stimulated antibody-dependent cell-mediated cytotoxicity.
    Connolly JM; Wunderlich JR
    J Immunol; 1980 Apr; 124(4):1917-23. PubMed ID: 7365243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of blood donation on antibody-dependent cellular cytotoxicity (ADCC) in voluntary blood bank donors.
    Lasek W; Jakóbisiak M; Płodziszewska M; Górecki D
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):37-43. PubMed ID: 3233062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against antibody-dependent cell-mediated cytotoxicity as a possible mechanism of liver cell injury in cystic fibrosis.
    Mondelli MU
    Boll Ist Sieroter Milan; 1987; 66(1):66-9. PubMed ID: 3620122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.